Physicochemical Properties
| Molecular Formula | C5H10NO5P |
| Molecular Weight | 195.11 |
| Exact Mass | 195.029 |
| CAS # | 2004714-32-1 |
| Related CAS # | POMHEX;2004714-34-3 |
| PubChem CID | 122540907 |
| Appearance | Brown to reddish brown viscous liquid |
| Density | 1.7±0.1 g/cm3 |
| Boiling Point | 486.8±55.0 °C at 760 mmHg |
| Flash Point | 248.2±31.5 °C |
| Vapour Pressure | 0.0±2.6 mmHg at 25°C |
| Index of Refraction | 1.577 |
| LogP | -3.5 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 12 |
| Complexity | 236 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | P(C1C(N(CCC1)O)=O)(=O)(O)O |
| InChi Key | DVZQUMSQEGOYMX-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C5H10NO5P/c7-5-4(12(9,10)11)2-1-3-6(5)8/h4,8H,1-3H2,(H2,9,10,11) |
| Chemical Name | (1-hydroxy-2-oxopiperidin-3-yl)phosphonic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| Targets | Ki: 74.4 nM (ENO2), 269.4 nM (ENO1)[1]. |
| References |
[1]. Enolase inhibitors and methods of treatment there with. WO2016145113A1. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (512.53 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (10.66 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (10.66 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.08 mg/mL (10.66 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.1253 mL | 25.6266 mL | 51.2531 mL | |
| 5 mM | 1.0251 mL | 5.1253 mL | 10.2506 mL | |
| 10 mM | 0.5125 mL | 2.5627 mL | 5.1253 mL |